Reckitt Benckiser Group Plc ADR (OP:RBGLY)

13.09 -0.06 (-0.46%)

Delayed Quote Updated: 3:59 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Reckitt Benckiser Group Plc ADR

< Previous 1 2 3 4 5 6 Next >

Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Reckitt Benckiser Group PLC (OTC: RBGLY)

June 05, 2025

From Scott+Scott Attorneys at Law LLP

Via Business Wire

Reckitt Benckiser's $5B Essential Home Divestment Falters As Bids Miss Mark: Report ↗

June 04, 2025

Reuters reported that the company will continue to pursue the divestment.

Via Stocktwits

Topics Government

KKR Outbids Competitors To Secure $2.9 Billion Karo Healthcare Takeover ↗

April 09, 2025

KKR is closing in on a $2.9B takeover of Karo Healthcare after outbidding rivals, reinforcing its aggressive push into European healthcare.

Via Benzinga

RBGLY Investors Have Opportunity to Join Reckitt Benckiser Group plc Securities Fraud Investigation with the Schall Law Firm

January 30, 2025

From The Schall Law Firm

Via Business Wire

Carlyle Pays $300M For Majority Ownership In India's VLCC ↗

January 10, 2023

Via Benzinga

Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation into Reckitt Benckiser Group PLC (OTC: RBGLY)

December 05, 2024

From Scott+Scott Attorneys at Law LLP

Via Business Wire

FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns ↗

November 08, 2024

FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.

Via Benzinga

What You Missed On Wall Street This Past Friday ↗

November 03, 2024

Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.

Via Talk Markets

British Consumer Company Reckitt Benckiser's CEO Steps Down ↗

September 01, 2022

Via Benzinga

Abbott Laboratories' Attractive Valuation Ranks It Among Top Large-Cap MedTech Companies, Says Analyst ↗

September 19, 2024

Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.

Via Benzinga

Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula ↗

September 18, 2024

Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale...

Via Benzinga

Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know. ↗

July 29, 2024

ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.

Via InvestorPlace

Abbott Laboratories Tumble Nearly 8% In Pre-Market After US Jury Charges $495M Penalty For Disease Causing Baby Formula ↗

July 29, 2024

This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.

Via Benzinga

Topics Lawsuit

Similac Baby Formula Maker Abbott And Reckitt Face Hundreds Of Baby Formula Lawsuits ↗

July 08, 2024

Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt...

Via Benzinga

Topics Lawsuit

What's Going On With Abbott Laboratories Stock On Friday? ↗

March 15, 2024

An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about...

Via Benzinga

Topics Lawsuit

Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online ↗

February 29, 2024

Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight.

Via Benzinga

NVDA Stock on Fire: Can Potential Nvidia Investors Still Get In or Will They Get Burned? ↗

January 28, 2024

Nvidia could generate $100 billion in free cash flow over the next two years. That’s excellent news for Nvidia stock.

Via InvestorPlace

Reckitt's Mead Johnson Initiates Massive Recall Of 675K Cans Of Hypoallergenic Baby Formula Over Bacteria Contamination Fears ↗

January 01, 2024

A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves approximately 675,000 cans of infant formula.

Via Benzinga

Pumpkin Spice Profits: Take a Sip of SBUX Stock Before the End of the Year ↗

October 29, 2023

Starbucks continues to deliver healthy growth across its operating regions. However, China is the key to SBUX stock.

Via InvestorPlace

FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch ↗

September 12, 2023

According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for...

Via Benzinga

3 Consumer Staples Stocks to Dump ASAP ↗

August 02, 2023

There are plenty of strong, inflation-beating picks out there, so these three consumer staples stocks to sell are best left alone.

Via InvestorPlace

Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process ↗

May 24, 2023

Via Benzinga

7 Established Stocks That Are Poised for Growth in 2023 ↗

March 22, 2023

The youngest of these stocks that are poised for growth in 2023 was founded in 1993. In other words, they are all established names.

Via InvestorPlace

Abbott Laboratories Under DOJ Investigation Into 2022 Baby Formula Plant Shutdown: Report ↗

January 21, 2023

The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories (NYSE: ABT).

Via Benzinga

The Viral “Tripledemic” Opportunity ↗

January 14, 2023

Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu...

Via Talk Markets

Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report ↗

December 02, 2022

Via Benzinga

The “Procter & Gamble Of The UK” Is Now On My Watchlist ↗

October 17, 2022

One of the larger companies in the UK, parts of which have been around for 200+ years, is Reckitt Benckiser Group plc. I like to think of it as the Procter & Gamble of the UK.

Via Talk Markets

Short Volatility Alert: Reckitt Benckiser Group plc ↗

September 19, 2022

On Friday, shares of Reckitt Benckiser Group plc (OTC: RBGLY) experienced volatile short activity. After the activity, the stock price went down -1.96% to $14.48. The overall sentiment for RGBLY has...

Via Benzinga

New Starbucks CEO To Focus On Unions, Pay And Benefits As Part Of 'Reinvention' Plan ↗

September 04, 2022

Starbucks Corporation (NYSE: SBUX) surprised everyone this week by naming Reckitt Benckiser Group plc (OTC: RBGLY)

Via Benzinga

Why This Starbucks Analyst Is Surprised By New CEO Choice — And Optimistic ↗

September 02, 2022

Starbucks Corporation (NYSE: SBUX) announced late Thursday the appointment of Reckitt Benckiser Group plc (OTC: RBGLY) top brass

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.